Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)

CAPS Rating: 5 out of 5

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.

Results 1 - 20 of 388 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar OklaBoston (64.23) Submitted: 1/28/2016 6:26:49 PM : Underperform Start Price: $60.68 TEVA Score: +1.91

Topping out with mostly crummy valuations and truly lousy Q/Q numbers.

Recs

0
Member Avatar kembs (63.79) Submitted: 1/5/2016 2:35:02 PM : Outperform Start Price: $65.13 TEVA Score: -4.24

Good , solid management........expected groundbreaking accomplishments ahead

Recs

0
Member Avatar jkb31 (< 20) Submitted: 11/12/2015 10:56:48 AM : Outperform Start Price: $59.05 TEVA Score: +8.85

Good Entry Point, a lot of positive things happening within the company.

Recs

0
Member Avatar Janetgaye (< 20) Submitted: 9/22/2015 5:20:33 PM : Outperform Start Price: $62.33 TEVA Score: -2.39

Buying up other drug companies,earning growth

Recs

0
Member Avatar 2trpop (90.94) Submitted: 9/17/2015 8:34:46 AM : Outperform Start Price: $64.27 TEVA Score: -2.38

fstg experiment

Recs

0
Member Avatar wimbouman (92.31) Submitted: 8/15/2015 6:00:10 AM : Outperform Start Price: $67.96 TEVA Score: -3.44

Generic medicine

Recs

0
Member Avatar Herbstmd (36.07) Submitted: 8/8/2015 9:01:47 AM : Outperform Start Price: $69.93 TEVA Score: -5.63

Growing company, high tech country, well positioned to yptake advantage of American push toward using generics with obamacare and insurance rules.good dividend.

Recs

0
Member Avatar Turtlebale (62.09) Submitted: 7/21/2015 5:54:24 PM : Outperform Start Price: $62.40 TEVA Score: +5.23

winner in consolidation

Recs

0
Member Avatar lkotkin128 (< 20) Submitted: 5/13/2015 12:49:24 PM : Outperform Start Price: $60.25 TEVA Score: +8.26

Worldwide coverage. Innovation in acquiring drugs with expiring patents, and an, apparently, very deep management team.

Recs

0
Member Avatar ELPastor (< 20) Submitted: 2/13/2015 9:57:28 AM : Outperform Start Price: $56.00 TEVA Score: +15.30

This company seems quite cyclical but appears to be improving revenue and upping its dividend over the past three years.

Recs

0
Member Avatar captainsandeen (< 20) Submitted: 1/21/2015 1:33:27 PM : Outperform Start Price: $57.27 TEVA Score: +9.96

position and knows its market

Recs

1
Member Avatar thecashmen (44.77) Submitted: 6/2/2014 6:20:06 PM : Outperform Start Price: $50.38 TEVA Score: +19.16

I work in a pharmacy and teva sell the most drugs by far. I look at their numbers and they are solid but who cares about the numbers when I see with my own two eyes that their product sell by the truckload

Recs

0
Member Avatar TerryFool (< 20) Submitted: 6/1/2014 7:53:32 PM : Outperform Start Price: $49.23 TEVA Score: +22.15

2015 EPS 4.77, PE est 10.6

Recs

0
Member Avatar afewgoodstocks11 (22.76) Submitted: 5/16/2014 5:29:19 PM : Outperform Start Price: $36.33 TEVA Score: +47.64

Div. (Yield) $1.18 (2.3%)
Current Yield . . . . . . 3.5%

Recs

0
Member Avatar SnowBawl (< 20) Submitted: 5/15/2014 7:57:08 AM : Outperform Start Price: $48.33 TEVA Score: +22.17

4 Big Elderly. Reeves.

Recs

0
Member Avatar BTE78 (45.80) Submitted: 4/24/2014 2:02:39 AM : Outperform Start Price: $48.71 TEVA Score: +21.00

It's one of these stocks that's worth a gamble and one that I'm willing to play on for the long haul.

Recs

0
Member Avatar InvestmentMAGE (38.55) Submitted: 3/22/2014 3:06:06 PM : Outperform Start Price: $47.91 TEVA Score: +22.24

John Neff Screen

Recs

0
Member Avatar DrGarnicus (60.99) Submitted: 3/11/2014 2:53:29 PM : Outperform Start Price: $47.82 TEVA Score: +22.64

Many new possibilities on the horizon.

Recs

0
Member Avatar drugtrader (91.18) Submitted: 2/21/2014 4:56:04 PM : Outperform Start Price: $40.28 TEVA Score: +43.82

This company is tremendously undervalued. They have a good-sized market share of generic drugs in the US (that are going up in price) and expanding their brand patents. Will likely see $60 in one year as the sector continues to rise on what I perceive to be a realization that drugs are more valuable than gold.

Recs

0
Member Avatar gcswim54 (< 20) Submitted: 2/21/2014 2:08:16 AM : Outperform Start Price: $46.72 TEVA Score: +24.12

George Soros is increasing his market share here. Also it is hitting a good timing period in several generic patent expiration's. Should be a good hold for a year or so.

Featured Broker Partners